Company research / TMDX
TransMedics Group, Inc. (TMDX)
- Sector Manufacturing
- Incorporated MA
- Fiscal year ends around Dec 31
For the year ended 2025-12-31, TransMedics Group, Inc. reported revenue of $605.49M. Revenue grew 37.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $668.47M.
Key ratios (year ended 2025-12-31)
59.9%
Gross margin
17.9%
Operating margin
31.4%
Net margin
40.2%
Return on year-end equity
37.1%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.